Korean J Gastroenterol.  2014 Jul;64(1):62-65. 10.4166/kjg.2014.64.1.62.

Does Helicobacter pylori Eradication Therapy Reduce the Risk of Developing Gastric Cancer in Healthy Asymtomatic Individuals?

• Kim YJ
• Chung WC

• KMID: 1791898
• DOI: http://doi.org/10.4166/kjg.2014.64.1.62

Abstract

No abstract available.

MeSH Terms

Anti-Bacterial Agents/*therapeutic use
Antioxidants/*therapeutic use
Helicobacter Infections/*drug therapy
Helicobacter pylori
Humans
Randomized Controlled Trials as Topic
Risk Reduction Behavior
Stomach Neoplasms/*prevention & control
Treatment Outcome
Vitamins/*therapeutic use
Anti-Bacterial Agents
Antioxidants
Vitamins

Figure

• 

  Fig. 1. Forest plot of randomized controlled trials of Helicobacter pylori eradication therapy: effect on subsequent occurrence of gastric cancer. Revised from the article of Ford et al. (BMJ 2014;348:g3174).4 df, degree of freedom.

• 

  Fig. 2. Forest plot of randomized controlled trials of Helicobacter pylori eradication therapy: effect on subsequent occurrence of gastric cancer according to presence or absence of pre-neoplastic lesions at baseline. Revised from the article of Ford et al. (BMJ 2014;348:g3174).4 df, degree of freedom.

• 

  Fig. 3. Forest plot of randomised controlled trials of Helicobacter pylori eradication therapy: effect on subsequent occurrence of gastric cancer according to anti-oxidant or vitamin use. Revised from the article of Ford et al. (BMJ 2014;348:g3174).4 df, degree of freedom.

Reference

References

1. Correa P. The gastric precancerous process. Cancer Surv. 1983; 2:437–450.

2. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet. 1975; 2:58–60.

3. Fuccio L, Zagari RM, Eusebi LH, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 2009; 151:121–128.

4. Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and metaanalysis of randomised controlled trials. BMJ. 2014; 348:g3174.

5. Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst. 2000; 92:1881–1888.

6. Gail MH, Brown LM, You W. Re: chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst. 2001; 93:559–560.

7. Saito D, Boku N, Fujioka T, et al. Impact of H. pylori eradication on gastric cancer prevention: endoscopic results of the japanese intervention trial (JITHP-Study). A randomized multicenter trial. Gastroenterology. 2005; 128(Suppl 2):A4.

8. Wong BC, Lam SK, Wong WM, et al. China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004; 291:187–194.

9. Wong BC, Zhang L, Ma JL, et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut. 2012; 61:812–818.

10. Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012; 104:488–492.

11. Zhou L. Ten-year follow-up study on the incidence of gastric cancer and the pathological changes of gastric mucosa after H. pylori eradication in China. Gastroenterology. 2008; 134(Suppl 1):A233.

12. Leung WK, Lin SR, Ching JY, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut. 2004; 53:1244–1249.

13. You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of pre-cancerous gastric lesions. J Natl Cancer Inst. 2006; 98:974–983.

14. Fukase K, Kato M, Kikuchi S, et al. Japan Gast Study Group. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008; 372:392–397.

15. Choi J, Kim SG, Yoon H, et al. Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma. Clin Gastroenterol Hepatol. 2014; 12:793–800.

16. Lee YC, Chen TH, Chiu HM, et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut. 2013; 62:676–682.